![Antithrombotic therapy in atrial fibrillation: aspirin is rarely the right choice | Postgraduate Medical Journal Antithrombotic therapy in atrial fibrillation: aspirin is rarely the right choice | Postgraduate Medical Journal](https://pmj.bmj.com/content/postgradmedj/89/1052/346/F3.large.jpg)
Antithrombotic therapy in atrial fibrillation: aspirin is rarely the right choice | Postgraduate Medical Journal
![Bleeding During Treatment With Aspirin Versus Apixaban in Patients With Atrial Fibrillation Unsuitable for Warfarin | Stroke Bleeding During Treatment With Aspirin Versus Apixaban in Patients With Atrial Fibrillation Unsuitable for Warfarin | Stroke](https://www.ahajournals.org/cms/asset/ae1d4f62-1d89-45e6-a77e-177b70848cd3/3291fig03.jpeg)
Bleeding During Treatment With Aspirin Versus Apixaban in Patients With Atrial Fibrillation Unsuitable for Warfarin | Stroke
![References in Thromboembolic, bleeding, and mortality risks among patients with nonvalvular atrial fibrillation treated with dual antiplatelet therapy versus oral anticoagulants: A population-based study - Heart Rhythm References in Thromboembolic, bleeding, and mortality risks among patients with nonvalvular atrial fibrillation treated with dual antiplatelet therapy versus oral anticoagulants: A population-based study - Heart Rhythm](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/8a0aa113-6f1f-442e-b028-2c62a6f40125/gr1.jpg)
References in Thromboembolic, bleeding, and mortality risks among patients with nonvalvular atrial fibrillation treated with dual antiplatelet therapy versus oral anticoagulants: A population-based study - Heart Rhythm
![Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial - The Lancet Neurology Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial - The Lancet Neurology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/11064ab7-590c-4e3c-bf44-87df147d66be/gr1_lrg.jpg)
Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial - The Lancet Neurology
![Cost–effectiveness of an insertable cardiac monitor to detect atrial fibrillation in patients with cryptogenic stroke | Journal of Comparative Effectiveness Research Cost–effectiveness of an insertable cardiac monitor to detect atrial fibrillation in patients with cryptogenic stroke | Journal of Comparative Effectiveness Research](https://www.futuremedicine.com/na101/home/literatum/publisher/fum/journals/content/cer/2021/cer.2021.10.issue-2/cer-2020-0224/20210205/images/medium/cer-2020-0224ga.eps.gif)
Cost–effectiveness of an insertable cardiac monitor to detect atrial fibrillation in patients with cryptogenic stroke | Journal of Comparative Effectiveness Research
![Atrial Fibrillation and Atrial Flutter - Heart and Blood Vessel Disorders - MSD Manual Consumer Version Atrial Fibrillation and Atrial Flutter - Heart and Blood Vessel Disorders - MSD Manual Consumer Version](https://www.msdmanuals.com/-/media/manual/home/images/c/v/s/cvs_ecg_reading.gif?thn=0&sc_lang=en)
Atrial Fibrillation and Atrial Flutter - Heart and Blood Vessel Disorders - MSD Manual Consumer Version
![Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial - The Lancet Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2000990157/2003648134/gr1.gif)
Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial - The Lancet
![Frontiers | Antithrombotic Management for Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention or With Acute Coronary Syndrome: An Evidence-Based Update | Cardiovascular Medicine Frontiers | Antithrombotic Management for Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention or With Acute Coronary Syndrome: An Evidence-Based Update | Cardiovascular Medicine](https://www.frontiersin.org/files/Articles/660986/fcvm-08-660986-HTML/image_m/fcvm-08-660986-g001.jpg)
Frontiers | Antithrombotic Management for Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention or With Acute Coronary Syndrome: An Evidence-Based Update | Cardiovascular Medicine
![Net clinical benefit of adding aspirin to warfarin in patients with atrial fibrillation: Insights from the J-RHYTHM Registry - International Journal of Cardiology Net clinical benefit of adding aspirin to warfarin in patients with atrial fibrillation: Insights from the J-RHYTHM Registry - International Journal of Cardiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/8f663c5d-4c4c-496f-9395-832cc5552290/gr1_lrg.jpg)